Showing results (61-70 of 95) with videos related to
Sort By:
Pageof 10
Journal of Chemotherapy (Florence, Italy)|February 26, 2013
Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in JapanIkuo Kudawara, Yasuaki Aoki, Takafumi Ueda, et al.Journal of Chemotherapy (Florence, Italy)|April 15, 2016
Trabectedin is a promising antitumour agent for synovial sarcomaHirohiko Yasui, Yoshinori Imura, Hidetatsu Outani, et al.Stem Cells (Dayton, Ohio)|June 3, 2010
Synovial sarcoma is a stem cell malignancyNorifumi Naka, Satoshi Takenaka, Nobuhito Araki, et al.International Journal of Oncology|February 10, 2004
Prediction of response to neoadjuvant chemotherapy for osteosarcoma by gene-expression profilesKensuke Ochi, Yataro Daigo, Toyomasa Katagiri, et al.Molecular and Clinical Oncology|July 9, 2019
Favorable outcomes of localized synovial sarcoma patients with a high utilization rate of neoadjuvant and/or adjuvant chemotherapyHidetatsu Outani, Shigeki Kakunaga, Kenichiro Hamada, et al.BMC Cancer|May 18, 2017
Therapeutic potential of TAS-115 via c-MET and PDGFRα signal inhibition for synovial sarcomaShutaro Yamada, Yoshinori Imura, Takaaki Nakai, et al.International Orthopaedics|April 24, 2019
Survival analysis of elderly patients with osteosarcomaYoshinori Imura, Satoshi Takenaka, Shigeki Kakunaga, et al.Molecular Cancer Therapeutics|December 5, 2019
Eribulin Suppresses Clear Cell Sarcoma Growth by Inhibiting Cell Proliferation and Inducing Melanocytic Differentiation Both Directly and Via Vascular RemodelingSho Nakai, Hironari Tamiya, Yoshinori Imura, et al.Cancer Management and Research|October 29, 2020
Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology GroupTomoki Nakamura, Jun Sugaya, Norifumi Naka, et al.The Journal of Molecular Diagnostics : JMD|April 29, 2005
Quantification of SSX mRNA expression in human bone and soft tissue tumors using nucleic acid sequence-based amplificationNorifumi Naka, Susumu Joyama, Yoshitane Tsukamoto, et al.Pageof 10